Content of review 1, reviewed on January 10, 2022

The research article supports the possibility to use YAP1-MALM2 fusions as a diagnostic biomarker to distinguish metaplastic thymoma from both type A and micronodular thymoma.

  • The manuscript is well presented, providing a good background for studies in this area.

  • The figures are exhaustive and well described

  • The manuscript is short with few experiments

Conflicts of interest

Do you have any conflicts of interest here? NO

Source

    © 2022 the Reviewer (CC BY 4.0).

References

    Jikai, Z., Ruiying, Z., Chan, X., Jinchen, S., Lianying, G., Yuchen, H. 2021. YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma. Frontiers in Oncology.